Sublocade (Buprenorphine Extended-Release) for Opioid Recovery
Overview Sublocade is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe opioid use disorder (OUD) in individuals who have already started treatment with a transmucosal…